The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

12 articles for P Sleph


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of Highly Potent Liver X Receptorß Agonists.EBI
Bristol-Myers Squibb
Discovery of hydroxyl 1,2-diphenylethanamine analogs as potent cholesterol ester transfer protein inhibitors.EBI
Bristol-Myers Squibb Pharmaceutical Research Institute
Tetrahydroisoquinoline 1-carboxamides as growth hormone secretagogues.EBI
Bristol-Myers Squibb Pharmaceutical Research Institute
Small molecule mitochondrial F1F0 ATPase hydrolase inhibitors as cardioprotective agents. Identification of 4-(N-arylimidazole)-substituted benzopyran derivatives as selective hydrolase inhibitors.EBI
The Bristol-Myers Squibb Pharmaceutical Research Institute
(D)-2-tert-Butoxycarbonylamino-5,5-difluoro-5-phenyl-pentanoic acid: synthesis and incorporation into the growth hormone secretagogues.EBI
Bristol Myers Squibb
Tetrazole based amides as growth hormone secretagogues.EBI
Bristol-Myers Squibb Research and Development
Optimization of 1H-tetrazole-1-alkanenitriles as potent orally bioavailable growth hormone secretagogues.EBI
Bristol-Myers Squibb Pharmaceutical Research Institute
Design and synthesis of tetrazole-based growth hormone secretagogue: the SAR studies of the O-benzyl serine side chain.EBI
Bristol Myers Squibb
Discovery of tertiary aminoacids as dual PPARalpha/gamma agonists-I.EBI
Bristol-Myers Squibb Pharmaceutical Research Institute
Design and synthesis of N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5- methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [Muraglitazar/BMS-298585], a novel peroxisome proliferator-activated receptor alpha/gamma dual agonist with efficacious glucose and lipid-lowering activities.EBI
Bristol-Myers Squibb Pharmaceutical Research Institute
Potent Triazolopyridine Myeloperoxidase Inhibitors.EBI
Bristol-Myers Squibb Research and Development
6,7-dihydropyrido[2,1-A]phthalazin-2-ones for the treatment and prophylaxis of hepatitis B virus infectionBDB
Hoffmann-La Roche